Eluvixtamab - CAS 1679391-73-1

Eluvixtamab (AMG-330) is a bispecific T-cell engager targeting CD33. It recognizes a linear epitope within the CD33 V-set domain, with a core sequence of IPYYDKN. By binding to CD33 on AML cells and CD3 on T cells, Eluvixtamab facilitates the destruction of CD33+ cells by T cells.

1679391-73-1

-20°C

Ice Packs

Inhibitory Antibodies